Search results for "Infectious Diseases"
Two studies show effectiveness of mRNA boosters against omicron variant
Other recent research on COVID-19 revealed the high transmissibility of the omicron stealth variant and changes in the brain after SARS-CoV-2 infection.
15 Mar 2022
Long-acting treatments may play a role in eradication of HCV
A cross-sectional survey of patients with or at risk for hepatitis C virus (HCV) found a high acceptability of long-acting treatments such as injections or implants, although daily oral medications were preferred by most. The authors noted that long-acting treatments might contribute to global efforts to eliminate HCV infection.
2 Nov 2021
ACP, Annals of Internal Medicine host fifth forum on COVID-19
“COVID-19 Forum V: Evaluation and Care of Patients with Persistent Symptoms Following Acute SARS-CoV-2 Infection” was held on June 9.
15 Jun 2021
More data on risk factors for poor COVID-19 outcomes, mixed results from treatment trials
A risk calculator, genetic findings, and red blood cell distribution width helped predict severity of and death from COVID-19. Tocilizumab showed benefit, but a number of other treatments, including CPR, did not, according to recent research.
29 Sep 2020
Most specialty e-consults appropriate, reduced in-person visits in one health system
A study found that about 70% of electronic consultations to five high-volume specialties were appropriate, ranging from 61% for rheumatology to 78% for psychiatry.
14 Apr 2020
Boosters, antithrombotic therapy, mental health effects, more COVID-19 news
FDA advisors recommended booster administration for the Moderna vaccine for certain populations, an ACP/Annals forum covered the immunology of SARS-CoV-2, a trial showed that neither aspirin nor apixaban benefited outpatients with COVID-19, and ACP partnered with YouTube to combat medical misinformation related to COVID-19.
19 Oct 2021
New research on PASC, COVID-19 infection and vaccination during pregnancy
Two studies analyzed postacute sequelae of COVID-19 (PASC) in older and ICU patients. Other new research showed that symptomatic infection during delivery raised risks in pregnant women but vaccination during pregnancy was safe. An ACP/Annals of Internal Medicine forum focused on outpatient management of COVID-19, and the FDA issued an emergency use authorization for a new monoclonal antibody treatment.
15 Feb 2022
Mixed findings on remdesivir for COVID-19, news on SARS-CoV-2 vaccines
Among other news this week, the NIH and the WHO released results from remdesivir trials, more negative findings were published for hydroxychloroquine, and ACP and Annals of Internal Medicine held a vaccine forum featuring Anthony S. Fauci, MD, MACP, and other experts.
20 Oct 2020
Guideline addresses viral testing in patients with community-acquired pneumonia
The new American Thoracic Society guideline opposes routine use of nucleic acid-based testing for noninfluenza viral pathogens in outpatients with community-acquired pneumonia but identifies some uses for the tests in inpatients.
11 May 2021
Advice on monoclonal antibodies; new data on long-term COVID-19 symptoms, vaccine efficacy
The NIH offered guidance on prioritization when monoclonal antibodies can't be given to all eligible patients. Two studies looked at patients with persistent COVID-19 symptoms, and other research confirmed the safety and effectiveness of the vaccines, even with the delta variant.
14 Sep 2021